II. СИСТЕМА АУТОТОЛЕРАНТНОСТИ И ЕЕ ФУНКЦИОНИРОВАНИЕ ПРИ ТРАНСПЛАНТАЦИИ АЛЛОГЕННЫХ ОРГАНОВ

центральная толерантность, периферическая толерантность, костный мозг, Т-регуляторные клетки, трансплантационная толерантность.

1. Быков В.Л. Цитология и общая гистология. СПб.: Со- тис, 2001.

2. Зайчик А.Ш., Чурилов Л.П. Патофизиология. Т. 1: Общая патофизиология. СПб.: ЭЛБИ-СПб, 2002.

3. Зотиков Е.А., Бабаева А.Г., Порешина Л.П. Клеточный химеризм и химеризм клетки при трансплантации костного мозга. М.: Хризостом, 2003. 112 с.

4. Рабсон А., Ройт А., Делвз П. Основы медицинской иммунологии. М.: Мир, 2006.

5. Ройт А., Бростофф Д., Мейл Д. Иммунология. М.: Мир, 2000.

6. Adams A.B., Durham M.M., Kean L., Shirasugi N. et al. Costimulation Blockade, Busulfan, and Bone Marrow Promote Titratable Macrochimerism, Induce Transplan- tation Tolerance, and Correct Genetic Hemoglobinopa- thies with Minimal Myelosuppression // Journal of Im- munology. 2001. Vol. 167. P. 1103–1111.

7. Adeegbe D., Bayer A.L,, Levy R.B. and Malek Cutting Edge. Allogeneic CD4+CD25+Foxp3+ T Regulatory Cells Suppress Autoimmunity while Establishing Transplanta- tion Tolerance // Journal of Immunology. 2006. Vol. 176. P. 7149–7153.

8. Alexander S.J., Smith N., Hu M. et al. Chimerism and tolerance in a recipient of a deceased – donor liver trans- plant // NEJM. 2008. Vol. 358 (4). P. 369–374.

9. Allan S.E., Alstad A.N., Merindol N. et al. Generation of potent and stable human CD4 – T regulatory cells by ac- tivation – independent expression of Foxp3 // Mol. Ther. 2008. Vol. 16. P. 194–202.

10. Bhattacharya D., Rossi D.J., Bryder D., Weissman I.L. Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning // J. Exp. Med. 2005. Vol. 203 (1). P. 73–85.

11. Botstein D., Crabtree G.R., Brown P.O. Genomic ex-

12. pression programs and the integration of the CD28 co- stimulatory signal in T cell activation // PNAS. 2002. Vol. 99 (18). P. 11796–11801.

13. Burchill M.A., Yang J., Vang K.B. et al. Linked T-cell receptor and cytokine signaling govern the development of the regulatory T-cell repertoire // Immunity. 2008. Vol. 28. P. 112–121.

14. Caudy A.A., Reddy S.T., Chatila T. et al. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome and defective IL-10 expression // J. Allerg. Clin. Immunol. 2007. Vol. 119. P. 482–487.

15. Czechowicz A., Kraft D., Weissman I.L., Bhattacharya D. Efficient Transplantation via Antibody-Based Clear- ance of Hematopoietic Stem Cell Niches // Science. 2007. Vol. 318 (5854). P. 1296–1299.

16. Demirkiran A., Bosma B.M., Kok A. et al. Allosup- pressive Donor CD4+CD25+ Regulatory T-Cells De- tach from the Graft and Circulate in Recipients after Liver Transplantation // Journal of Immunology. 2007. Vol. 178. P. 6066–6072.

17. Fontenot J.D., Dooley J.L., Farr A.G., Rudensky A.Y. Developmental regulation of Foxp3 expression during ontogeny // J. Exp. Med. 2005. Vol. 202. P. 901–906.

18. Fudaba Y., Spitzer T.R., Shaffer J. et al. Myeloma Re- sponses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: in vivo and in vitro Analyses // American Journal of Transplantation. 2006. Vol. 9 (6). P. 2121–2133.

19. Haddad E.M., McAlister V.C., Renouf E. et al. Cyclo- sporin versus tacrolimus for liver transplanted patients // The Cochrane Library. 2008. Issue 4.

20. Jiang H., Chess L. Regulation of Immune Responses by T Cells // NEJM. 2006. Vol. 11 (354). P. 1166–1176.

21. Joffre O., Santolaria T., Calise D. et al. Prevention of acute

22. and chronic allograft rejection with CD4+CD25+Foxp3 regulatory T-lymphocytes // Nat. Med. 2008. Vol. 14. P. 888–892.

23. Kawai T., Cosimi B., Spitzer T.R. et al. HLA-Mismatched Renal Transplantation without Maintenance Immuno- suppression // NEJM. 2008. Vol. 4 (358). P. 353–361.

24. Kyewski B., Klein L. A central thymic role for central tolerance // Annu. Rev. Immunol. 2006. Vol. 24. P. 571– 606.

25. Lee M.K., Moore D.J., Jarrett B.P. et al. Promotion of Allograft Survival by CD4+CD25+ Regulatory T-Cells: Evidence for In Vivo Inhibition of Effector Cell Prolife- ration // Journal of Immunology. 2004. Vol. 172. P. 6539– 6544.

26. Martinez-Agosto J.A., Mikkola H.K.A., Hartenstein V., Banerjee U. The hematopoietic stem cell and its niche: a comparative view Genes & Dev. 2007. Vol. 21. P. 3044– 3060.

27. Mathis D., Benoist C. Back to central tolerance // Immu- nity. 2004. Vol. 20. P. 509–516.

28. Noris M., Casiraghi F., Todeschini M. et al. Regulatory T-cells and T-cell depletion: role of immunosuppressive

29. drugs // J. Am. Soc. Nephrol. 2007. Vol. 18. P. 1007–

30.

31. Noris M., Cugini D., Casiraghi F. et al. Thymic Micro-

32. chimerism Correlates with the Outcome of Tolerance- Inducing Protocols for Solid Organ Transplantation // J. Am. Soc. Nephrol. 2001. Vol. 12. P. 2815–2826.

33. Penninghon D.J., Silva-Santos B., Silberzahn T. et al. Early events in the thymus affect the balance of effector and regulatory T-cells // Nature. 2006. Vol. 444. P. 1073– 1077.

34. Pham S.M., Rao A.S., Zeevi A., Kormos R.L. et al. A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results // J. Tho- rac. Cardiovasc. Surg. 2000. Vol. 119. P. 673–681.

35. Roncarolo M.G., Battaglia M. Regulatory T-cell immu- notherapy for tolerance to self antigens and alloantigens in humans // Nat. Rev. Immunol. 2007. Vol. 7. P. 585– 598.

36. Sakaguchi S., Sakaguchi N., Asano M. et al. Immunolo- gic self-tolerance maintained by activated T-cells expres- sing IL-2 receptor-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases // J. Immunol. 1995. Vol. 160. P. 1151–1164.

37. Sakaguchi S. Naturally arising CD4(+) regulatory T- cells for immunologic self-tolerance and negative con- trol of immune responses // Annu. Rev. Immunol. 2004. Vol. 22. P. 531–562.

38. Salama A.D., Najafian N., Clarkson M.R., Harmon W.E., Sayegh M.H. Regulatory CD25+ T Cells in Human Kid- ney Transplant Recipients // J. Am. Soc. Nephrol. 2003. Vol. 14. P. 1643–1651.

39. Salama A.D., Womer K.L., Sayegh M.H. Clinical Trans- plantation Tolerance: Many Rivers to Cross // Journal of Immunology. 2007. Vol. 178. P. 5419–5423.

40. Sayegh M.H., Carpenter C.B. Transplantation 50 Years Later – Progress, Challenges, and Promises // NEJM. 2004. Vol. 26 (351). P. 2761–2766.

41. Scandling J.D., Busque S., Dejbakhsh-Jones S. et al. Tolerance and Chimerism after Renal and Hematopoie- tic-Cell Transplantation // NEJM. 2008. Vol. 4 (358). P. 362–368.

42. Segundo D., Ruiz J.C., Izquierdo M. et al. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T-cells in renal trans- plant recipients // Transplantation. 2006. Vol. 82. P. 550– 557.

43. Shevach E.M. Certified professionals: CD4+CD25+ sup- pressor T cells // J. Exp. Med. 2001. Vol. 193. P. 41–46.

44. Starzl T.E., Zinkernagel R.M. Antigen Localization and Migration in Immunity and Tolerance // NEJM. 1998. Vol. 26 (339). P. 1905–1913.

45. Starzl T.E. Chimerism and tolerance in transplantation // PNAS. 2004. Vol. 101 (2). P. 14607–14614.

46. Stassen M., Jonuleit H., Muller C. et al. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation and proliferation of Th2 cells // J. Immunol. 2004. Vol. 173. P. 267–274.

47. Tarbell K.V., Yamazaki S., Olson K., Toy P., Stein- man R.M. CD25+ CD4+ T-Cells, Expanded with Dend- ritic Cells Presenting a Single Autoantigenic Peptide,Suppress Autoimmune Diabetes // JEM. Vol. 199. No 11.

48. P. 1467–1477.

49. Trivedia H.L., Vanikarb A.V., Modid P.R. et al. Allogenetic Hematopoietic Stem-Cell Transplantation, Mixed Chimerism, and Tolerance in Living Related Donor Re- nal Allograft Recipients // Transplantation Proceedings. 2005. Vol. 37 (2). P. 737–742.

50. Wekerle T., Sykes M. Mixed chimerism as an approach for the induction of transplantation tolerance // Trans- plantation. 1999. Vol. 68 (4). P. 459–467.

51. Wood K.J., Sakaguchi S. Regulatory T-cells in trans- plantation tolerance // Nat. Rev. Immunol. 2003. Vol. 3. P. 199–210.

52. Zenz T., Ritgen M., Dreger P. et al. Autologous graft-ver- sus-host disease – like syndrome after an alemtuzumab- containing conditioning regimen and autologous stem

53. cell transplantation for chronic lymphocytic leukemia //

54. Blood. 2006. Vol. 108 (6). P. 2127–2130.

55. Zhang J., Li L. Stem Cell Niche: Microenvironment and Beyond // J. Biol. Chem. 2008. Vol. 283 (15). P. 9499–9503.

56. Zheng S.G., Wang J., Wang P. et al. IL-2 is essential for TGF- to convert naïve CD4+CD25-cells to CD25+Foxp3 regulatory T-cells and for expansion of these cells // J. Immunol. 2007. Vol. 178. P. 2018–2027.

57. Zheng Y., Collins S.L., Lutz M.A. et al. A Role for Mammalian Target of Rapamycin in Regulating T-Cell Ac- tivation versus Anergy // The Journal of Immunology. 2007. Vol. 178. P. 2163–2170.

58. Zheng Y., Rudensky A.Y. Foxp3 in control of the regula- tory T-cell lineage // Nat. Immunol. 2007. Vol. 8. P. 457– 462.